C5 Congress: Myriad decision "will not" affect patenting in Europe


Aliki Nichogiannopoulou, director of biotechnology at the European Patent Office, outlined best practices for patenting antibodies at the office while speaking at the 25th C5 Congress on Biotech and Pharma Patenting in London on Wednesday.

Patent, Myriad, EPO, Biotech, Pharma